Search results
Clinical Utility of Realtime Three-dimensional Echocardiography - A New and Emerging Standard
Author(s):
Tamar S Polonsky
,
Victor Mor-Avi
,
Roberto M Lang
Added:
3 years ago
Article
Author(s):
Matthew R Weir
Added:
3 years ago
The lower level to which blood pressure should be taken and how soon treatment should be started are key considerations where aging and cardiovascular mortality risks are concerned. It has long been taught that blood pressure should be allowed to rise to a level deemed pre-hypertensive or hypertensive before non-pharmacological and pharmacological therapy is embarked upon. Is this really the…
View more
Homocysteine and Heart Disease
Author(s):
Kilmer S McCully
Added:
3 years ago
Article
Author(s):
Gurushankar Govindarajan
,
James R Sowers
,
Craig S Stump
Added:
3 years ago
There has been an increase in the prevalence of diabetes mellitus over the past 40 years, both in the US and worldwide. The worldwide prevalence of diabetes in 2000 was approximately 2.8% and is estimated to grow to 4.4% by 2030. This translates to a projected rise of diabetes from 171 million in 2000 to well over 350 million in 2030. The epidemic of diabetes will continue to rise as there is…
View more
Author(s):
Robert A Vogel
Added:
3 years ago
There are about 65 million Americans (or 20–25% of the population) with hypertension.As a top line figure that is probably a little low as it uses the rather strict definition of high blood pressure as being 140 over 90.Hypertension is also very strongly age-related, and as we get older that frequency goes up a lot. Essentially, 95% of Americans will be hypertensive in their lifetime. It is a…
View more
Homocysteine and Heart Disease
Author(s):
Kilmer S McCully
Added:
3 years ago
Article
Author(s):
Domenic A Sica
Added:
3 years ago
A not inconsequential number of therapeutic agents or chemical substances can increase blood pressure (BP). The degree to which BP increases determines whether a specific definitional threshold has been crossed, at which time the patient is designated as having become hypertensive. Drugs that cause hypertension do so by either causing vasoconstriction, increasing extracellular fluid (ECF) volume,…
View more
Author(s):
Albert Alahmar
,
Anthony H Gershlick
Added:
3 years ago
Drug-eluting stents (DES) have revolutionized the field of interventional cardiology. The US Food and Drug Administration (FDA) is expecting that the total number of DES implanted in 2010 will surpass 5 million worldwide. Although initial results seemed promising, longer-term follow-up in a wider range of patients revealed some concerns. Enhanced platelet aggregation, delayed neointimal growth, a…
View more
Chest Pain in Women
Author(s):
Mariem A Sawan
,
Rebecca S Steinberg
,
Michael N Sayegh
,
et al
Added:
4 months ago
Article